8-Hydroxyquinoline-2-carbonitrile, 95+%, 5g

N-(4-aminophenyl)-4-methylbenzenesulfonamide, 1g

tert-Butyl 2-oxo-1,7-diazaspiro[3.5]nonane-7-carboxylate, 95.0%, 100mg

2-Chloroquinazolin-4(3H)-one, 90.0%, 10g

(R)-2-Carboxymethyl-pyrrolidine-1-carboxylic acidtert-butyl ester, 95.0%, 5g

2,6-Dibromo-4-fluoroaniline, 98.0%, 500g

4-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 10g

4-Bromopyridine-2,6-dicarboxylic acid, 95.0%, 250mg

7-(3-Chloro-4-methylphenyl)-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol, 95.0%, 500mg

Methyl-(1-thiazol-2-yl-ethyl)-amine, 95.0%, 250mg

5-Cyano-2-methylindole-3-acetic acid, 97.0%, 100mg

Colonne capillaire GC ROTI®Cap-5 HT, 15 m, 0,25 mm, 0,10 µm, 1 pièce(s)

(2-((3R,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)cyclohexylidene)ethyl)diphenylphosphine oxide, 98%, 250mg